High Dose Rate Brachytherapy of Localized Prostate Cancer

Slides:

Advertisements

Similar presentations

Volume 53, Issue 3, Pages (March 2008)

Advertisements

Volume 62, Issue 3, Pages (September 2012)

Volume 155, Issue 3, Pages (March 1996)

MP60-03 PROSTATE CANCER IN THE ELDERLY

The PSA Era is not Over for Prostate Cancer

Volume 66, Issue 2, Pages (August 2014)

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

Volume 58, Issue 4, Pages (October 2010)

Volume 47, Issue 4, Pages (April 2005)

Volume 68, Issue 6, Pages e129-e131 (December 2015)

Volume 52, Issue 5, Pages (November 2007)

Volume 49, Issue 2, Pages (February 2006)

Volume 61, Issue 5, Pages (May 2012)

Volume 53, Issue 5, Pages (May 2008)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 51, Issue 4, Pages (April 2007)

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Volume 53, Issue 5, Pages (May 2008)

Prostate Cancer Epidemic in Sight?

Volume 52, Issue 4, Pages (October 2007)

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Volume 61, Issue 1, Pages (January 2012)

Volume 66, Issue 2, Pages (August 2014)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 4, Pages (October 2015)

Volume 68, Issue 5, Pages (November 2015)

Volume 71, Issue 1, Pages 1-3 (January 2017)

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 67, Issue 6, Pages (June 2015)

Counselling the Prostate Cancer Patient

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 53, Issue 2, Pages (February 2008)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 4, Pages (October 2010)

Volume 53, Issue 6, Pages (June 2008)

Volume 63, Issue 3, Pages (March 2013)

Volume 62, Issue 4, Pages (October 2012)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Volume 41, Issue 2, Pages (February 2002)

Volume 68, Issue 4, Pages (October 2015)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 66, Issue 6, Pages (December 2014)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Volume 70, Issue 1, Pages (July 2016)

How and When to Take Prostate Biopsies

Challenges and Opportunities in Hormone-Resistant Prostate Cancer

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Volume 54, Issue 1, Pages (July 2008)

Volume 53, Issue 6, Pages (June 2008)

Management of Prostate Cancer: Global Strategies

Treatment Options in Prostate Cancer Once Primary Therapy Fails

Manfred Wirth, Peter Iversen, David McLeod, William See

Volume 50, Issue 6, Pages (December 2006)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Volume 52, Issue 1, Pages (July 2007)

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Epidemiology and Demographics of Prostatitis

Jan Roigas European Urology Supplements

Neal S Goldstein, MD The Annals of Thoracic Surgery

Volume 54, Issue 1, Pages (July 2008)

Presentation transcript:

High Dose Rate Brachytherapy of Localized Prostate Cancer Serdar Deger, Dirk Boehmer, Ingolf Türk, Jan Roigas, Klaus Dieter Wernecke, Thomas Wiegel, Wolfgang Hinkelbein, Stefan Dinges, Volker Budach, Stefan A. Loening European Urology Volume 41, Issue 4, Pages 420-426 (April 2002) DOI: 10.1016/S0302-2838(02)00016-7

Fig. 1 Progression-free survival according to initial PSA value. European Urology 2002 41, 420-426DOI: (10.1016/S0302-2838(02)00016-7)

Fig. 2 Progression-free survival according PSA nadir. European Urology 2002 41, 420-426DOI: (10.1016/S0302-2838(02)00016-7)

Fig. 3 Progression-free survival according to clinical stage. European Urology 2002 41, 420-426DOI: (10.1016/S0302-2838(02)00016-7)

Fig. 4 Progression-free survival according to tumor differentiation. European Urology 2002 41, 420-426DOI: (10.1016/S0302-2838(02)00016-7)